RKT · Consumer staples · one day
Reckitt (RKT): news on Thursday 5 November 2026
News from the 24 hours to Thursday morning, 5 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was mostly mild and positive, centred on a new Mucinex product launch and royalty deals that left the shares steady. Reckitt's finance chief also winning a UPS board seat added a small positive note.
What drove it
- Mucinex launch
- royalty deals
- CFO board appointment
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 30 Oct | −2.0 | 13 |
| Sat 31 Oct | −5.5 | 5 |
| Mon 2 Nov | +6.5 | 4 |
| Tue 3 Nov | +3.0 | 5 |
| Wed 4 Nov | +6.3 | 4 |
| Thu 5 Nov | +3.3 | 4 |
3 stories · 4 headlines · strongest first
Consumer staples on 5 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| UPS appoints Reckitt CFO to its board +1.82 headlines today · Shannon Eisenhardt, Reckitt's finance chief, has been appointed to the UPS board. | ||
| +2.0 | Reckitt's finance chief gains external board seat, mildly reflecting well on its leadership. | |
| +1.7 | Same board appointment of Reckitt's CFO elsewhere, modest positive for standing. | |
| Reckitt launches Mucinex Recharge +4.01 headline today · 3 in all, since 30 October · A piece says the Mucinex Recharge launch is a test for the stock. | ||
| +5.0 | New product launch seen as important test, with potential upside for the shares. | |
| Higher royalty payments may squeeze Reckitt margins −1.41 headline today · 2 in all, since 3 November · A piece says new royalty deals leave the stock steady. | ||
| +4.2 | Royalty agreements and steady shares with continuing investor support. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Reckitt: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.